Shouse, Geoffrey <br/><br/>
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.  [electronic resource] 

 -  Current hematologic malignancy reports  12 2019 
 - 570-576 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1558-822X 
<br/><br/><label>Standard No.: </label>10.1007/s11899-019-00545-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Diagnosis, Differential<br/>Disease Management<br/>Disease Susceptibility<br/>Humans<br/>Janus Kinases--metabolism<br/>Lymphoproliferative Disorders--diagnosis<br/>Molecular Targeted Therapy--methods<br/>STAT Transcription Factors--metabolism<br/>Signal Transduction--drug effects<br/>T-Lymphocytes--drug effects<br/>Treatment Outcome